Yes I know CP. I just imagine a huge round table where the BP reps sit around discussing the major changes in biotech and each one wanting ...errr...rather needing the anti-PS platform to lock up their immunotherapy angle....
Their drugs need a control rod to stop a runaway immune response from what I understand. Is bavituximab and our PS targeting technology that control rod?
Market Data 
Markets 
AI
